CoChat

Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s Disease

Uberti, Daniela, Lanni, Cristina, Racchi, Marco, Govoni, Stefano, Memo, Maurizio · 2008 · Neurodegenerative Diseases
Cited by 34

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The identification of biological markers of Alzheimer’s disease (AD) can be extremely useful to improve diagnostic accuracy and/or to monitor the efficacy of putative therapies. In this regard, peripheral cells may be of great importance because of their easy accessibility. After subjects were grouped according to diagnosis, the expression of conformational mutant p53 in blood cells was compared by immunoprecipitation or by a cytofluorimetric assay. One hundred and four patients with AD, 92 age-matched controls, 15 patients with Parkinson’s disease, and 9 with other types of dementia were analyzed. Two independent methods to evaluate the differential expression of a conformational mutant p53 were developed. Mononuclear cells were analyzed by immunoprecipitation or by flow cytometric analysis, following incubation with a conformation-specific p53 antibody, which discriminates unfolded p53 tertiary structure. Mononuclear cells from AD patients express a statistically significantly higher amount of mutant-like p53 compared to mononuclear cells from non-AD subjects, thus supporting the study of conformational mutant p53 as a new putative marker to discriminate AD from non-AD patients. We also observed a strong positive correlation between the expression of p53 and the age of patients. The expression of mutant p53 did not correlate with the duration of illness and the Mini Mental State Examination scores.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000113704

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • CSF markers for incipient Alzheimer's disease

    Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291 · cited 1×

    “This paper shall focus on the use of existing and emerging biomarkers as additional diagnostic measures in a population clinically identified as having AD. Biological Markers for ADA wide variety of different proteins such as inflammatory markers, markers of oxidative stress, apolipoproteins, and markers of neuronal d…”
    Background

Show all 1 references

Cited by

See all 34

Metadata

Authors
Uberti, D., Lanni, C., Racchi, M., Govoni, S., & Memo, M.
Venue
Neurodegenerative Diseases
Publisher
S. Karger AG
Published
2008
Volume
5
Issue
3-4
Pages
209-211
ISSN
  • 1660-2854 (ISSN-L)
  • 1660-2862
OpenAlex
W2011075986
Cited by
34
References
1
FWCI
2.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s Disease. https://app.cochat.ai/papers/10.1159/000113704
The paper
Uberti, D., Lanni, C., Racchi, M., Govoni, S., & Memo, M. (2008). Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s Disease. Neurodegenerative Diseases. https://doi.org/10.1159/000113704

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.